{"nct_id":"NCT04895358","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-02","start_date":"2021-06-18","start_date_type":"ACTUAL","primary_completion_date":"2027-12-18","primary_completion_date_type":"ESTIMATED","completion_date":"2027-12-18","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}